Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes.

Virtanen, S M; Bärlund, S; Salonen, M; Savilahti, E; Reunanen, A; Paronen, J; Hämäläinen, A-M; Ilonen, J; Teramo, K; Erkkola, M; Ormisson, A; Einberg, Ü; Riikjärv, M-A; Ludvigsson, J G; Knip, M; Åkerblom, H K

Virtanen, S M; Bärlund, S; Salonen, M; Savilahti, E; Reunanen, A; Paronen, J; Hämäläinen, A-M; Ilonen, J; Teramo, K; Erkkola, M; Ormisson, A; Einberg, Ü; Riikjärv, M-A; Ludvigsson, J G; Knip, M; Åkerblom, H K.

Affiliation

Virtanen SM; Nutrition Unit, National Institute for Health and Welfare, Helsinki, Finland.

Acta Paediatr ; 100(4): 557-64, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21114527

Subject(s)

Diabetes Mellitus, Type 1/prevention & control; Infant Formula/administration & dosage; Patient Compliance/statistics & numerical data; Primary Prevention/methods; Animals; Caseins/analysis; Diabetes Mellitus, Type 1/genetics; Feasibility Studies; Genetic Predisposition to Disease; Humans; Immunoglobulin A/immunology; Immunoglobulin G/immunology; Infant; Infant Formula/chemistry; Infant Nutritional Physiological Phenomena; Milk/chemistry; Pilot Projects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Primary Prevention / Patient Compliance / Infant Formula / Diabetes Mellitus, Type 1 Type of study: Clinical_trials / Etiology_studies / Qualitative_research / Risk_factors_studies Limits: Animals / Humans / Infant Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google